Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1

被引:67
作者
Li, Xiaochun [1 ]
Stankovic, Milena [1 ]
Bonder, Claudine S. [1 ]
Hahn, Christopher N. [1 ]
Parsons, Michelle [1 ]
Pitson, Stuart M. [1 ]
Xia, Pu [2 ]
Proia, Richard L. [3 ]
Vadas, Mathew A. [2 ]
Gamble, Jennifer R. [2 ]
机构
[1] Inst Med & Vet Sci, Hanson Inst, Div Human Immunol, Adelaide, SA, Australia
[2] Univ Sydney, Centenary Inst Canc Med & Cell Biol, Med Fdn, Sydney, NSW, Australia
[3] NIDDK, Natl Inst Hlth, Genet Dev & Dis Branch, Bethesda, MD USA
关键词
D O I
10.1182/blood-2007-05-092148
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Endothelial cells (ECs) regulate the barrier function of blood vessels. Here we show that basal and angiopoietin-1 (Ang-1)-regulated control of EC permeability is mediated by 2 different functional states of sphingosine kinase-1 (SK-1). Mice depleted of SK-1 have increased vascular leakiness, whereas mice transgenic for SK-1 in ECs show attenuation of leakiness. Furthermore, Ang-1 rapidly and transiently stimulates SK-1 activity and phosphorylation, and induces an increase in intracellular sphingosine-1-phosphate (S1P) concentration. Overexpression of SK-1 resulted in inhibition of permeability similar to that seen for Ang-1, whereas knockdown of SK-1 by small interfering RNA blocked Ang-1-mediated inhibition of permeability. Transfection with SKS225A, a nonphosphorylatable mutant of SK-1, inhibited basal leakiness, and both SKS225A and a dominant-negative SK-1 mutant removed the capacity of Ang-1 to inhibit permeability. These effects were indepen-dent of extracellular S1P as knockdown or inhibition of S1P(1), S1P(2), or S1P(3), did not affect the Ang-1 response. Thus, SK-1 levels in ECs powerfully regulate basal permeability in vitro and in vivo. In addition, the Ang-1-induced inhibition of leakiness is mediated through activation of SK-1, defining a new signaling pathway in the Ang-1 regulation of permeability.
引用
收藏
页码:3489 / 3497
页数:9
相关论文
共 37 条
[1]   Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720 [J].
Allende, ML ;
Sasaki, T ;
Kawai, H ;
Olivera, A ;
Mi, YD ;
van Echten-Deckert, G ;
Hajdu, R ;
Rosenbach, M ;
Keohane, CA ;
Mandala, S ;
Spiegel, S ;
Proia, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (50) :52487-52492
[2]   Adaptor ShcA protein binds tyrosine kinase Tie2 receptor and regulates migration and sprouting but not survival of endothelial cells [J].
Audero, E ;
Cascone, I ;
Maniero, F ;
Napione, L ;
Arese, M ;
Lanfrancone, L ;
Bussolino, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :13224-13233
[3]   Signaling and functions of angiopoietin-1 in vascular protection [J].
Brindle, NPJ ;
Saharinen, P ;
Alitalo, K .
CIRCULATION RESEARCH, 2006, 98 (08) :1014-1023
[4]   Sphingosine 1-phosphate analogs as receptor antagonists [J].
Davis, MD ;
Clemens, JJ ;
Macdonald, TL ;
Lynch, KR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (11) :9833-9841
[5]   Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway [J].
DeBusk, LM ;
Hallahan, DE ;
Lin, PC .
EXPERIMENTAL CELL RESEARCH, 2004, 298 (01) :167-177
[6]   Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation [J].
Feistritzer, C ;
Riewald, M .
BLOOD, 2005, 105 (08) :3178-3184
[7]   Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions [J].
Gamble, JR ;
Drew, J ;
Trezise, L ;
Underwood, A ;
Parsons, M ;
Kasminkas, L ;
Rudge, J ;
Yancopoulos, G ;
Vadas, MA .
CIRCULATION RESEARCH, 2000, 87 (07) :603-607
[8]  
Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI200112450
[9]   Vascular endothelial growth factor vascular permeability factor produces nitric oxide-dependent hypotension - Evidence for a maintenance role in quiescent adult endothelium [J].
Horowitz, JR ;
Rivard, A ;
vanderZee, R ;
Hariawala, M ;
Sheriff, DD ;
Esakof, DD ;
Chaudhry, GM ;
Symes, JF ;
Isner, JM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :2793-2800
[10]   Angiopoietin-1 opposes VEGF-induced increase in endothelial permeability by inhibiting TRPC1-dependent Ca2+ influx [J].
Jho, D ;
Mehta, D ;
Ahmmed, G ;
Gao, XP ;
Tiruppathi, C ;
Broman, M ;
Malik, AB .
CIRCULATION RESEARCH, 2005, 96 (12) :1282-1290